Therapy Areas
All Sessions
Resectable NSCLC
Metastatic NSCLC
SCLC
Biomarkers & Diagnostics
DRUG CLASSES
Targeted Therapies
Immuno-therapies
Antibody-Drug Conjugates
View Sessions
Dec
18
2025
METASTATIC NSCLC, SCLC
2025 Approvals & Highlights
1 h 49 min
Sep
26
2025
SCLC
RESHAPING APPROACHES IN SCLC WITH THE LATEST ADVANCES IN LS- AND ES-DISEASE
34 min
Sep
26
2025
METASTATIC NSCLC
LATEST OPTIONS FOR NON-ONCOGENE ADDICTED METASTATIC NSCLC IN FRONTLINE AND BEYOND
32 min
Sep
26
2025
IMMUNOTHERAPIES
THE ROLE OF IO ADDED TO CHEMORADIATION IN UNRESECTABLE STAGE III NSCLC
28 min
Sep
26
2025
IMMUNOTHERAPIES
TAILORING IO IN RES. NSCLC: PERSONALIZED APPROACHES FOR IMPROVED OUTCOMES
36 min
Sep
26
2025
METASTATIC NSCLC
Open Discussion on Patient Cases
22 min
Jun
25
2025
IMMUNOTHERAPIES
Immunotherapies in NSCLC
1h 47 min
Jun
17
2025
SCLC
Small Cell Lung Cancer
1h 35 min
Oct
04
2024
METASTATIC NSCLC, RESECTABLE NSCLC
Patient Cases & Open Questions
32 min
Oct
04
2024
SCLC
Reshaping Our Approaches in SCLC: Latest Therapeutic Options and Future Strategies
25 min
Oct
04
2024
METASTATIC NSCLC
DEBATE: Balancing Efficacy, Toxicity, and Patient-Centered Care For IO Duration in NSCLC
33 min
Oct
04
2024
IMMUNOTHERAPIES
Tailoring IO in Resectable NSCLC: Personalized Approaches for Improved Outcomes
25 min